Cullen Frost Bankers Inc. Lowers Holdings in Humana Inc. $HUM

Cullen Frost Bankers Inc. trimmed its holdings in Humana Inc. (NYSE:HUM) by 8.8% in the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 890 shares of the insurance provider’s stock after selling 86 shares during the period. Cullen Frost Bankers Inc.’s holdings in Humana were worth $218,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in HUM. Cary Street Partners Investment Advisory LLC grew its position in Humana by 63.9% in the first quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider’s stock worth $31,000 after acquiring an additional 46 shares during the period. Zions Bancorporation National Association UT purchased a new position in Humana in the first quarter worth approximately $37,000. Ransom Advisory Ltd purchased a new position in Humana in the first quarter worth approximately $66,000. Transamerica Financial Advisors LLC boosted its position in shares of Humana by 1,027.6% during the first quarter. Transamerica Financial Advisors LLC now owns 327 shares of the insurance provider’s stock worth $87,000 after buying an additional 298 shares during the period. Finally, Tower View Wealth Management LLC purchased a new position in shares of Humana during the second quarter worth $88,000. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research analysts have recently commented on HUM shares. Piper Sandler lowered their price target on Humana from $288.00 to $272.00 and set a “neutral” rating for the company in a research report on Thursday, July 31st. Truist Financial set a $300.00 price target on Humana in a research report on Tuesday, October 14th. Mizuho raised their price target on Humana from $300.00 to $345.00 and gave the stock an “outperform” rating in a research report on Thursday, October 9th. Sanford C. Bernstein raised their price target on Humana from $269.00 to $341.00 and gave the stock an “outperform” rating in a research report on Friday, September 5th. Finally, The Goldman Sachs Group began coverage on Humana in a research report on Tuesday, October 14th. They set a “sell” rating and a $235.00 price target for the company. Eight research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $297.58.

Humana Trading Down 0.2%

NYSE:HUM opened at $290.66 on Friday. The firm has a market cap of $34.96 billion, a PE ratio of 22.31, a price-to-earnings-growth ratio of 1.70 and a beta of 0.42. The stock has a fifty day moving average price of $281.65 and a 200 day moving average price of $258.97. Humana Inc. has a 12-month low of $206.87 and a 12-month high of $315.35. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $6.32 by ($0.05). The business had revenue of $32.39 billion for the quarter, compared to analysts’ expectations of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%.The firm’s quarterly revenue was up 9.6% on a year-over-year basis. During the same period last year, the firm earned $6.96 earnings per share. Humana has set its FY 2025 guidance at 17.000- EPS. Sell-side analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.2%. The ex-dividend date of this dividend is Friday, September 26th. Humana’s payout ratio is 27.17%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.